To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TPD52L1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
311 supporting clones for gene TPD52L1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC327742 caudate nucleus .a 1 to 578 1 to 578   tiling clone,   578/578
(100 %)
3 diff
(99.5 %id)
DN991475 brain, whole brain .a 93 to 737 9 to 653       645/653
(98 %)
6 diff
(99.1 %id)
BI603400 brain, hypothalamus .a 212 to 1110 1 to 883   tiling clone,   883/892
(98 %)
36 diff
(96.0 %id)
TI_45212614   .a 217 to 1110 91 to 968       878/977
(89 %)
36 diff
(96.4 %id)
BM546629 brain, hippocampus .a 228 to 1106 26 to 906   tiling clone,   881/1050
(83 %)
19 diff
(98.2 %id)
NM_003287.2   .b 1 to 1370 1 to 1370 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1370/1370
(100 %)
0 diff
(100 %id)
BM913790 astrocytoma grade IV, cell line, brain .b 35 to 815 1 to 787   tiling clone,   787/1098
(71 %)
29 diff
(97.4 %id)
U44427 breast carcinoma .b 40 to 1364 1 to 1325   tiling clone,   1325/1325
(100 %)
0 diff
(100 %id)
BE392179 endometrium, adenocarcinoma cell line, uterus .b 53 to 703 1 to 651       649/693
(93 %)
11 diff
(98.5 %id)
BP248256 Kidney .b 70 to 650 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CB216758 normal endometrium, mid-secretory phase,cycle day 23, uterus .b 72 to 671 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
BP346680 brain .b 79 to 661 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BU538830 adenocarcinoma, cell line, breast .b 86 to 838 1 to 763       763/816
(93 %)
18 diff
(97.8 %id)
BU856836 adenocarcinoma, cell line, breast .b 86 to 912 1 to 833       833/928
(89 %)
13 diff
(98.6 %id)
CN275131 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 97 to 801 1 to 705       705/705
(100 %)
2 diff
(99.8 %id)
BP332208 renal proximal tubule .b 108 to 675 1 to 568       568/568
(100 %)
4 diff
(99.3 %id)
CF147423 CNCAP(3)T-225 cell line, Prostate .b 112 to 696 1 to 584       584/584
(100 %)
9 diff
(98.5 %id)
TI_154180053   .b 118 to 852 69 to 796       728/911
(79 %)
22 diff
(97.6 %id)
BG761918 melanotic melanoma, high MDR (cell line), skin .b 119 to 757 1 to 637       637/637
(100 %)
3 diff
(99.6 %id)
BX509495   .b 132 to 833 1 to 702       702/702
(100 %)
1 diff
(99.9 %id)
BE266612 lung, small cell carcinoma .b 163 to 813 1 to 645       647/648
(99 %)
13 diff
(98.0 %id)
BX283407 lung, small cell carcinoma .b 188 to 696 1 to 509       509/509
(100 %)
1 diff
(99.9 %id)
CK431050 eye, lacrimal gland .b 195 to 809 1 to 615       615/615
(100 %)
0 diff
(100 %id)
AK291887 skeletal muscle .b 202 to 1364 1 to 1163       1163/1163
(100 %)
2 diff
(99.9 %id)
DA896827 skeletal muscle .b 203 to 760 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
BE263811 lung, small cell carcinoma .b 208 to 878 1 to 668       670/701
(95 %)
12 diff
(98.3 %id)
TI_59391268   .b 433 to 1141 71 to 780       710/710
(100 %)
1 diff
(99.9 %id)
BM020481 astrocytoma grade IV, cell line, brain .b 434 to 1141 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
CN275133 embryonic stem cells, DMSO-treated H9 cellline .b 454 to 936 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
BM712315 eye, lens .b 518 to 774 1 to 257       257/257
(100 %)
1 diff
(99.7 %id)
U44428 liver and spleen .b 534 to 1364 1 to 831       831/831
(100 %)
1 diff
(99.9 %id)
T89899 liver and spleen .b 535 to 898 1 to 368       368/417
(88 %)
17 diff
(96.0 %id)
AW389720 stomach .b 604 to 927 25 to 348       324/363
(89 %)
8 diff
(97.8 %id)
T93647 liver and spleen .b 606 to 774 1 to 171       171/171
(100 %)
7 diff
(96.0 %id)
BE207625 adenocarcinoma cell line, ovary .b 625 to 994 1 to 370   fully sequenced,   370/370
(100 %)
0 diff
(100 %id)
N99206 multiple sclerosis lesions .b 640 to 961 1 to 324   fully sequenced,   324/324
(100 %)
1 diff
(99.7 %id)
CA432078 cell lines, Enchondroma .b 647 to 1368 740 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 722/733
(98 %)
3 diff
(99.6 %id)
BM688879 eye, eye anterior segment .b 652 to 1094 19 to 461   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 443/461
(96 %)
6 diff
(98.7 %id)
CA420550 Bone, Enchondroma cell line .b 655 to 1364 728 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 710/710
(100 %)
0 diff
(100 %id)
N66206 multiple sclerosis lesions .b 931 to 1364 434 to 1   fully sequenced,   434/434
(100 %)
0 diff
(100 %id)
BE208357 adenocarcinoma cell line, ovary .b 964 to 1367 404 to 1   fully sequenced,   404/404
(100 %)
1 diff
(99.8 %id)
BU727163 eye, eye anterior segment .b 1064 to 1370 325 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 307/307
(100 %)
1 diff
(99.7 %id)
T89623 liver and spleen .b 1069 to 1366 313 to 12       302/314
(96 %)
0 diff
(100 %id)
T93603 liver and spleen .b 1131 to 1366 252 to 17       236/252
(93 %)
0 diff
(100 %id)
CN275129 embryonic stem cells, DMSO-treated H9 cellline .c 1 to 571 1 to 571   tiling clone,   571/571
(100 %)
0 diff
(100 %id)
BU956340 adenocarcinoma, cell line, breast .c 6 to 655 1 to 651       651/890
(73 %)
8 diff
(99.2 %id)
BQ641312 eye, normal pigmented retinal epithelium .c 58 to 894 1 to 843   tiling clone,   843/910
(92 %)
15 diff
(98.4 %id)
BE732907 choriocarcinoma, placenta .c 124 to 910 1 to 778   tiling clone,   778/846
(91 %)
18 diff
(97.9 %id)
NM_001003396.1   .d 1 to 1309 1 to 1309 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1309/1309
(100 %)
0 diff
(100 %id)
BG328591 adenocarcinoma cell line, colon .d 39 to 627 1 to 588   tiling clone,   588/588
(100 %)
3 diff
(99.5 %id)
CN275130 embryonic stem cells, DMSO-treated H9 cellline .d 51 to 646 1 to 596       596/596
(100 %)
5 diff
(99.2 %id)
BG110043 Bone, osteosarcoma, cell line .d 62 to 797 1 to 738       738/1006
(73 %)
13 diff
(98.8 %id)
BQ919269 large cell carcinoma, lung .d 85 to 1038 23 to 985       963/986
(97 %)
30 diff
(97.0 %id)
AW245739 lung, small cell carcinoma .d 98 to 656 1 to 559       559/559
(100 %)
5 diff
(99.2 %id)
BC002375 Lung, small cell carcinoma .d 107 to 1309 1 to 1203   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1203/1203
(100 %)
0 diff
(100 %id)
BF132273 hypernephroma, Kidney .d 113 to 645 1 to 543       543/740
(73 %)
23 diff
(96.9 %id)
BF219990 lung, small cell carcinoma .d 126 to 811 1 to 681       681/698
(97 %)
10 diff
(98.6 %id)
DN990523 brain, whole brain .d 180 to 799 1 to 620       620/620
(100 %)
4 diff
(99.4 %id)
DA898481 skeletal muscle .d 200 to 759 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CV026648 mixed .d 220 to 653 1 to 434       434/604
(71 %)
0 diff
(100 %id)
BP264911 muscle .d 331 to 1157 1 to 843       843/1054
(79 %)
18 diff
(98.3 %id)
TI_154108185   .d 360 to 1303 1032 to 94   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 939/973
(96 %)
19 diff
(98.1 %id)
TI_149311467   .d 476 to 1307 913 to 84   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 830/1007
(82 %)
7 diff
(99.4 %id)
CA447457 Chondrosarcoma, Left Pelvis .d 506 to 1303 816 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 798/798
(100 %)
1 diff
(99.9 %id)
CB160306 Liver .d 518 to 1084 1 to 567       567/567
(100 %)
0 diff
(100 %id)
BM977370 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 528 to 1307 796 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 778/778
(100 %)
3 diff
(99.7 %id)
BF220066 lung, small cell carcinoma .d 591 to 1267 677 to 1       677/677
(100 %)
2 diff
(99.8 %id)
W69680 heart .d 602 to 990 1 to 389   fully sequenced,   389/389
(100 %)
0 diff
(100 %id)
W69681 heart .d 960 to 1308 359 to 1   fully sequenced,   359/359
(100 %)
3 diff
(99.2 %id)
AA182908   .e 1 to 344 1 to 347   tiling clone,   347/347
(100 %)
9 diff
(97.5 %id)
BG698390 skin .e 43 to 831 1 to 783   tiling clone,   785/784
(100 %)
11 diff
(98.6 %id)
AA181574   .e 824 to 1264 444 to 1   tiling clone,   444/444
(100 %)
6 diff
(98.7 %id)
BP334548 salivary gland .f 1 to 568 1 to 568 exact tiling clone,   568/575
(98 %)
3 diff
(99.5 %id)
BG677422 skin, squamous cell carcinoma .f 7 to 817 1 to 814   tiling clone,   814/815
(99 %)
12 diff
(98.6 %id)
DA394996 thalamus .g 1 to 586 2 to 587   tiling clone, capped   586/586
(100 %)
1 diff
(99.9 %id)
BM045972 carcinoma, cell line, Prostate .g 453 to 1284 1 to 833       833/834
(99 %)
11 diff
(98.7 %id)
BM048527 carcinoma, cell line, Prostate .g 453 to 1391 1 to 943 K11N A12S E13R L14V V15S ... tiling clone,   943/943
(100 %)
39 diff
(95.9 %id)
BM047355 carcinoma, cell line, Prostate .g 453 to 1293 1 to 834       834/914
(91 %)
14 diff
(98.5 %id)
BQ895862 carcinoma, cell line, Prostate .g 455 to 1339 1 to 894 E13Q S131I S145R A154G A158G ... tiling clone,   894/911
(98 %)
21 diff
(97.7 %id)
BQ944814 carcinoma, cell line, Prostate .g 455 to 1318 1 to 867 H155M A156P S157G A158P Q159R ... tiling clone,   867/1001
(86 %)
13 diff
(98.8 %id)
BQ928174 carcinoma, cell line, Prostate .g 455 to 1414 1 to 969 F118X K119Q K135X S152F T168D ... tiling clone,   969/970
(99 %)
19 diff
(98.1 %id)
BQ928925 carcinoma, cell line, Prostate .g 455 to 1317 1 to 867 K41E V125G V149A A156G S165F ... tiling clone, AAA   867/947
(91 %)
14 diff
(98.6 %id)
BQ959084 carcinoma, cell line, Prostate .g 455 to 1180 1 to 728       728/959
(75 %)
11 diff
(98.9 %id)
BQ945245 carcinoma, cell line, Prostate .g 455 to 714 1 to 260   AAA   260/722
(36 %)
1 diff
(99.9 %id)
NM_001003395.1   .g 455 to 1845 1 to 1391   RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1391/1391
(100 %)
0 diff
(100 %id)
BP274119 Kidney .h 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
CB114736 Liver .i 1 to 557 1 to 557   tiling clone,   557/557
(100 %)
1 diff
(99.9 %id)
DA115395 cerebellum .i 3 to 573 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
BE409865 choriocarcinoma, placenta .i 5 to 708 32 to 733 G126A D127R M128H R129E R130T ...     702/738
(95 %)
13 diff
(98.3 %id)
NM_001003397.1   .i 5 to 1274 1 to 1270   RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1270/1270
(100 %)
0 diff
(100 %id)
BI560760 testis .i 7 to 919 5 to 917 L57W     913/928
(98 %)
34 diff
(96.4 %id)
TI_44349165   .i 7 to 919 89 to 1001 L57W     913/1012
(90 %)
30 diff
(97.1 %id)
CN272293 embryonic stem cells, DMSO-treated H9 cellline .i 11 to 188 1 to 178       178/178
(100 %)
4 diff
(97.8 %id)
BG490930 large cell carcinoma, lung .i 18 to 705 1 to 685       685/687
(99 %)
4 diff
(99.5 %id)
BU540537 large cell carcinoma, lung .i 20 to 939 1 to 925       925/926
(99 %)
13 diff
(98.6 %id)
DA037886   .i 24 to 592 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BF037260 adenocarcinoma, ovary .i 32 to 850 1 to 818       818/841
(97 %)
31 diff
(96.4 %id)
BP359533 mammary gland .i 33 to 610 1 to 577       577/582
(99 %)
6 diff
(99.0 %id)
BP319576 pericardium .i 36 to 616 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA867971 Prostate .i 36 to 573 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
AK291866 skeletal muscle .i 37 to 1259 1 to 1223   tiling clone,   1223/1223
(100 %)
0 diff
(100 %id)
DA893642 skeletal muscle .i 38 to 566 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
BQ933027 large cell carcinoma, lung .i 39 to 950 1 to 915       915/915
(100 %)
8 diff
(99.2 %id)
BG339353 leiomyosarcoma cell line, uterus .i 42 to 776 1 to 732 L57C S58Q A59R E61K R62G ...     732/853
(85 %)
17 diff
(98.1 %id)
CD558434 White Matter .i 42 to 795 27 to 784 K70Q K98R S122T R129T     758/921
(82 %)
35 diff
(96.2 %id)
BG332781 large cell carcinoma, lung .i 46 to 870 21 to 835       815/838
(97 %)
16 diff
(98.1 %id)
BM809770 astrocytoma grade IV, cell line, brain .i 49 to 931 1 to 886       886/1155
(76 %)
27 diff
(97.7 %id)
CN275132 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 50 to 547 90 to 587       498/587
(84 %)
5 diff
(99.2 %id)
BE379294 endometrium, adenocarcinoma cell line, uterus .i 55 to 403 10 to 356       347/356
(97 %)
6 diff
(98.4 %id)
BM542114 melanotic melanoma, skin .i 56 to 711 1 to 659 M128L R129T     659/1474
(44 %)
12 diff
(99.2 %id)
BI088018 cervix .i 58 to 752 1 to 695       695/696
(99 %)
3 diff
(99.6 %id)
CN275127 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 61 to 561 1 to 501       501/501
(100 %)
0 diff
(100 %id)
AA633641 schizophrenic brain S-11 frontal lobe .i 66 to 510 1 to 440     Submitted on the opposite strand 440/483
(91 %)
17 diff
(96.5 %id)
BE900695 choriocarcinoma, placenta .i 67 to 837 1 to 759 L57C S58Q A59R E61K R62G ...     759/808
(93 %)
27 diff
(96.7 %id)
CN275128 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 69 to 474 1 to 406       406/406
(100 %)
2 diff
(99.6 %id)
BI086202 astrocytoma grade IV, cell line, brain .i 71 to 573 44 to 547   fully sequenced,   504/547
(92 %)
12 diff
(97.9 %id)
BM552394 astrocytoma grade IV, cell line, brain .i 71 to 1013 16 to 966       951/1058
(89 %)
20 diff
(98.2 %id)
TI_59389889   .i 71 to 952 87 to 962       876/962
(91 %)
22 diff
(97.8 %id)
BM019209 astrocytoma grade IV, cell line, brain .i 79 to 952 1 to 868       868/868
(100 %)
17 diff
(98.1 %id)
AL709811 human skeletal muscle .i 85 to 586 1 to 502       502/502
(100 %)
5 diff
(99.1 %id)
CA454265   .i 89 to 738 1 to 649       649/716
(90 %)
2 diff
(99.8 %id)
CB113175 Liver .i 91 to 592 1 to 502       502/502
(100 %)
1 diff
(99.9 %id)
BP199237 brain .i 98 to 551 1 to 454       454/461
(98 %)
2 diff
(99.6 %id)
BP315759 mammary gland .i 98 to 680 1 to 583 S122X K123Q     583/583
(100 %)
1 diff
(99.9 %id)
BF724599 eye, Iris .i 99 to 505 1 to 407       407/407
(100 %)
0 diff
(100 %id)
DA975896 synovial membrane tissue from rheumatioidarthritis .i 99 to 629 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
BP329237 rectum .i 101 to 679 1 to 582 *132X     582/582
(100 %)
4 diff
(99.4 %id)
CA392266 eye, RPE/choroid .i 102 to 578 1 to 477       477/477
(100 %)
0 diff
(100 %id)
BP353473   .i 112 to 687 1 to 582 Q4H E19Q A21S V44A D48N ...     576/582
(98 %)
16 diff
(97.3 %id)
BI086949 cervix .i 118 to 929 1 to 806       806/806
(100 %)
18 diff
(97.8 %id)
CB157375 Liver .i 125 to 578 1 to 454       454/454
(100 %)
0 diff
(100 %id)
CB156905 Liver .i 125 to 540 1 to 416       416/416
(100 %)
0 diff
(100 %id)
BU538661 adenocarcinoma, cell line, breast .i 129 to 1033 1 to 909       909/909
(100 %)
22 diff
(97.6 %id)
BU944130 adenocarcinoma, cell line, breast .i 129 to 943 1 to 820       820/916
(89 %)
8 diff
(99.2 %id)
BE745891 adenocarcinoma cell line, ovary .i 130 to 942 1 to 801 L8C L9W E10R T11L E12N ...     803/928
(86 %)
26 diff
(97.2 %id)
BU538846 adenocarcinoma, cell line, breast .i 130 to 614 1 to 487       487/1003
(48 %)
11 diff
(99.0 %id)
BE264935 lung, small cell carcinoma .i 132 to 519 1 to 388       388/390
(99 %)
1 diff
(99.8 %id)
BE265305 lung, small cell carcinoma .i 132 to 814 1 to 678 L57C S58Q A59R E61K R62G ...     678/717
(94 %)
14 diff
(98.1 %id)
CA393269 eye, RPE/choroid .i 154 to 576 10 to 432       423/432
(97 %)
6 diff
(98.7 %id)
BF884408 lung_tumor .i 155 to 308 160 to 9     Submitted on the opposite strand 152/160
(95 %)
6 diff
(96.3 %id)
BM802217 duodenal adenocarcinoma, cell line, small intestine .i 163 to 1019 1 to 863       863/978
(88 %)
8 diff
(99.2 %id)
AK291872 skeletal muscle .i 167 to 1140 1 to 974 G107E     974/974
(100 %)
1 diff
(99.9 %id)
DC385564 skeletal muscle .i 167 to 722 1 to 556 G107E     556/556
(100 %)
1 diff
(99.9 %id)
BM019819 astrocytoma grade IV, cell line, brain .i 168 to 1080 1 to 920 L8C L9W E10R T11L E12N ...     922/924
(99 %)
33 diff
(96.5 %id)
TI_59390516   .i 169 to 1080 93 to 1011 L8C L9W E10R T11L E12N ...     921/923
(99 %)
32 diff
(96.6 %id)
AF208012   .i 185 to 738 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BG743666 skin .i 203 to 952 1 to 750       750/750
(100 %)
0 diff
(100 %id)
BG742719 skin .i 203 to 1033 1 to 829       829/833
(99 %)
8 diff
(99.1 %id)
W93489 heart .i 240 to 589 46 to 400       355/400
(88 %)
13 diff
(96.8 %id)
BE001793 breast_normal .i 267 to 609 369 to 29     Submitted on the opposite strand 339/374
(90 %)
1 diff
(99.8 %id)
BE001869 breast_normal .i 267 to 609 384 to 42     Submitted on the opposite strand 342/388
(88 %)
0 diff
(100 %id)
BE002053 breast_normal .i 267 to 609 370 to 26     Submitted on the opposite strand 345/376
(91 %)
10 diff
(97.4 %id)
BE002014 breast_normal .i 268 to 609 22 to 363       342/387
(88 %)
12 diff
(96.9 %id)
BU957723 adenocarcinoma, cell line, breast .i 507 to 1272 11 to 776   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 766/776
(98 %)
9 diff
(98.9 %id)
BU685117 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 515 to 1272 776 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 758/758
(100 %)
0 diff
(100 %id)
BU625292 cell lines, Enchondroma .i 515 to 1268 772 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 754/754
(100 %)
0 diff
(100 %id)
BU628410 cell lines, Chondrosarcoma .i 534 to 1268 745 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 727/727
(100 %)
12 diff
(98.4 %id)
BU634442 cell lines, Chondrosarcoma .i 534 to 1272 756 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 738/738
(100 %)
2 diff
(99.8 %id)
BI085858 astrocytoma grade IV, cell line, brain .i 543 to 1204 679 to 15   fully sequenced,   665/679
(97 %)
0 diff
(100 %id)
TI_151701462   .i 543 to 1272 840 to 116       725/1001
(72 %)
8 diff
(99.3 %id)
BQ001385 lung, Metastatic Chondrosarcoma .i 551 to 1268 737 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 719/721
(99 %)
1 diff
(99.9 %id)
T68402 Liver .i 556 to 857 13 to 321       309/323
(95 %)
20 diff
(93.9 %id)
BF094779 uterus_tumor .i 579 to 916 1 to 337       337/348
(96 %)
7 diff
(98.0 %id)
W93591 heart .i 845 to 1269 432 to 1       432/432
(100 %)
14 diff
(96.8 %id)
BM702179 eye, optic nerve .j 1 to 429 1 to 429 exact tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 429/429
(100 %)
0 diff
(100 %id)
BM664873 eye, optic nerve .j 399 to 892 512 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 494/494
(100 %)
1 diff
(99.8 %id)
AK124817 caudate nucleus .k 1 to 2489 1 to 2489   tiling clone, available from FLJ,   2489/2489
(100 %)
5 diff
(99.8 %id)
DA263965 caudate nucleus .k 2 to 552 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BP215937 corpus callosum .k 40 to 636 1 to 598       598/598
(100 %)
4 diff
(99.4 %id)
BU543063 carcinoma, cell line, Prostate .k 85 to 713 81 to 709       629/1083
(58 %)
12 diff
(98.9 %id)
BF801751 colon_ins .k 1689 to 2066 14 to 391       378/391
(96 %)
6 diff
(98.5 %id)
DB306775 caudate nucleus .k 1954 to 2489 537 to 1       537/537
(100 %)
3 diff
(99.5 %id)
BE407159 choriocarcinoma, placenta .l 1 to 773 1 to 772 exact tiling clone,   772/981
(78 %)
17 diff
(98.3 %id)
BE728349 melanotic melanoma, skin .l 1 to 800 1 to 792 M99I R100E R101T     792/822
(96 %)
24 diff
(97.1 %id)
BF026786 melanotic melanoma, skin .l 1 to 720 1 to 715 L28W G89E T90R A91P I92S ...     715/715
(100 %)
8 diff
(98.9 %id)
BQ432307 melanotic melanoma, skin .l 228 to 1103 1 to 893 exact     893/894
(99 %)
32 diff
(96.5 %id)
BU178699 melanotic melanoma, skin .l 231 to 1024 24 to 820 exact tiling clone,   797/830
(96 %)
14 diff
(98.4 %id)
BQ354265 head_neck .l 232 to 676 494 to 48 Q26P Q40P M44V K56Q K68Q ...     447/496
(90 %)
10 diff
(98.0 %id)
BE384117 melanotic melanoma, skin .l 239 to 857 1 to 617 L28C S29Q A30R E32N R33G ...     617/617
(100 %)
5 diff
(99.2 %id)
BE893447 melanotic melanoma, skin .l 243 to 934 1 to 687 exact     687/1002
(68 %)
20 diff
(98.1 %id)
BE619243 large cell carcinoma, lung .l 254 to 1068 1 to 800 K31E     800/979
(81 %)
40 diff
(96.0 %id)
AA055718 colon, tumor .l 266 to 628 1 to 365 E32X E49X K51X K69T E72X ...     365/365
(100 %)
3 diff
(99.2 %id)
BF724843 eye, Iris .l 322 to 952 1 to 631       631/631
(100 %)
0 diff
(100 %id)
AA055661 colon, tumor .l 812 to 1259 450 to 1   tiling clone,   450/450
(100 %)
2 diff
(99.6 %id)
DT215247 brain .m 1 to 685 1 to 685   tiling clone,   685/685
(100 %)
2 diff
(99.8 %id)
BF725814 eye, Iris .m 351 to 603 1 to 253       253/253
(100 %)
0 diff
(100 %id)
U44429 Liver .m 654 to 2279 1 to 1626   tiling clone,   1626/1626
(100 %)
2 diff
(99.9 %id)
AI807361 pooled .m 707 to 1369 663 to 3       661/690
(95 %)
0 diff
(100 %id)
TI_149298396   .m 707 to 1371 737 to 77   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 661/788
(83 %)
25 diff
(96.9 %id)
AI193115 lung .m 712 to 1373 679 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 663/663
(100 %)
23 diff
(96.6 %id)
BQ006862 Chondrosarcoma, Left Pelvis .m 722 to 1373 668 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 652/658
(99 %)
6 diff
(99.1 %id)
TI_149295638   .m 728 to 1371 732 to 86   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 647/950
(68 %)
7 diff
(99.3 %id)
BF805970 colon_ins .m 730 to 1064 340 to 1     Submitted on the opposite strand 340/347
(97 %)
22 diff
(93.7 %id)
BF823649 kidney_tumor .m 731 to 1171 441 to 1     Submitted on the opposite strand 441/443
(99 %)
5 diff
(98.9 %id)
CB529260 Aveolar Macrophage, lung .m 735 to 1373 655 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 639/639
(100 %)
0 diff
(100 %id)
TI_151718187   .m 735 to 1379 763 to 116       648/1078
(60 %)
29 diff
(97.4 %id)
BF805966 colon_ins .m 740 to 1072 1 to 335       335/335
(100 %)
9 diff
(97.4 %id)
BE964218 large cell carcinoma, lung .m 753 to 1373 677 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 662/662
(100 %)
34 diff
(94.9 %id)
AA608564 lung, lung carcinoma .m 770 to 1371 602 to 1       602/602
(100 %)
0 diff
(100 %id)
EC458313 Prostate .m 783 to 871 104 to 15       90/104
(86 %)
0 diff
(100 %id)
BQ345478 nervous_tumor .m 801 to 1178 409 to 30       380/409
(92 %)
0 diff
(100 %id)
CR599743 Placenta Cot 25-normalized .m 805 to 1356 1 to 552       552/552
(100 %)
0 diff
(100 %id)
BX335904 Placenta Cot 25-normalized .m 805 to 1369 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
AW815566 stomach .m 812 to 1175 372 to 9       364/393
(92 %)
0 diff
(100 %id)
BU683793 lung, Primary Lung Cystic Fibrosis EpithelialCells .m 812 to 1371 578 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 560/563
(99 %)
0 diff
(100 %id)
BQ772271 Chondrosarcoma Grade II, Left Pelvis .m 817 to 1373 573 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 557/557
(100 %)
0 diff
(100 %id)
TI_151739765   .m 819 to 1372 677 to 113       565/1097
(51 %)
0 diff
(100 %id)
AA576767 breast, breast tumor .m 827 to 1371 541 to 1       541/541
(100 %)
27 diff
(95.1 %id)
BM983140 lung, Primary Lung Cystic Fibrosis EpithelialCells .m 834 to 1371 555 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 537/537
(100 %)
7 diff
(98.7 %id)
AA702528 liver and spleen .m 853 to 1367 514 to 1       514/514
(100 %)
5 diff
(99.1 %id)
BF000433 colon, colon tumor, RER+ .m 855 to 1369 519 to 5       515/519
(99 %)
0 diff
(100 %id)
BG952201 colon .m 870 to 1169 1 to 299       299/299
(100 %)
2 diff
(99.4 %id)
AI286037 pooled .m 873 to 1369 496 to 1       496/499
(99 %)
6 diff
(98.8 %id)
BG285969 bladder, transitional cell papilloma, cell line .m 873 to 1371 20 to 516   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 497/516
(96 %)
7 diff
(98.7 %id)
AA535805 colon .m 878 to 1371 514 to 20   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 495/495
(100 %)
8 diff
(98.4 %id)
AI191454 lung .m 883 to 1369 482 to 2       481/482
(99 %)
0 diff
(100 %id)
AW189554 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m 894 to 1373 485 to 6       480/485
(98 %)
0 diff
(100 %id)
AW118159 pooled .m 902 to 1367 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI215598 pooled .m 921 to 1369 449 to 1       449/450
(99 %)
0 diff
(100 %id)
AI828582 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 922 to 1379 479 to 22       458/479
(95 %)
6 diff
(98.8 %id)
AI298348 placenta .m 923 to 1369 451 to 5       447/451
(99 %)
0 diff
(100 %id)
AI278449 placenta .m 925 to 1372 453 to 6       448/453
(98 %)
0 diff
(100 %id)
BE857949 pooled .m 933 to 1369 443 to 7       437/443
(98 %)
0 diff
(100 %id)
AI079797 parathyroid gland, parathyroid tumor .m 934 to 1369 441 to 5       437/441
(99 %)
0 diff
(100 %id)
AI370762 uterus .m 936 to 1371 436 to 1       436/436
(100 %)
0 diff
(100 %id)
AW149111 Kidney, renal cell tumor .m 940 to 1367 439 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 428/437
(97 %)
0 diff
(100 %id)
AI961427 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 941 to 1367 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI912472 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .m 942 to 1371 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AA948661 2 pooled tumors (clear cell type), Kidney .m 945 to 1377 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AI148254 senescent fibroblast .m 945 to 1369 430 to 6       425/430
(98 %)
0 diff
(100 %id)
AI524368 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .m 945 to 1369 427 to 4       424/427
(99 %)
0 diff
(100 %id)
BE045833 follicular carcinoma, thyroid .m 945 to 1367 438 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 423/423
(100 %)
0 diff
(100 %id)
AI185226 lung .m 947 to 1367 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AW014342   .m 948 to 1367 437 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 420/420
(100 %)
3 diff
(99.3 %id)
AW245382 lung, small cell carcinoma .m 948 to 1373 427 to 11   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 417/417
(100 %)
19 diff
(95.5 %id)
BX281122 testis .m 950 to 1364 450 to 32   AAA Submitted on the opposite strand 419/422
(99 %)
0 diff
(100 %id)
BQ002333 Chondrosarcoma, Left Pelvis .m 956 to 1377 439 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 422/422
(100 %)
0 diff
(100 %id)
DB530947 hippocampus .m 963 to 1367 1 to 405     Submitted on the opposite strand 405/405
(100 %)
1 diff
(99.8 %id)
AI014441 breast .m 966 to 1369 408 to 5       404/408
(99 %)
0 diff
(100 %id)
AA745950 Kidney .m 967 to 1367 401 to 1       401/401
(100 %)
0 diff
(100 %id)
BM662621 eye, optic nerve .m 968 to 1367 418 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 400/400
(100 %)
0 diff
(100 %id)
AW243683 adenocarcinoma, Pancreas .m 969 to 1368 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AA837838 colon, colon tumor .m 975 to 1369 396 to 2       395/396
(99 %)
0 diff
(100 %id)
CB047208 Kidney .m 986 to 1373 415 to 25   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 391/400
(97 %)
5 diff
(98.8 %id)
AA723205 heart .m 988 to 1367 397 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 380/380
(100 %)
0 diff
(100 %id)
CB108458 Liver .m 989 to 1352 11 to 374       364/374
(97 %)
6 diff
(98.4 %id)
AI828585 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 1007 to 1373 420 to 54   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 367/367
(100 %)
0 diff
(100 %id)
F26007 pectoral muscle (after mastectomy) .m 1008 to 1360 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
F36468 pectoral muscle (after mastectomy) .m 1015 to 1183 1 to 169       169/169
(100 %)
0 diff
(100 %id)
AI492371 Kidney .m 1019 to 1373 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AI810226 Prostate .m 1023 to 1379 368 to 12       357/368
(97 %)
5 diff
(98.7 %id)
AA632425   .m 1025 to 1369 359 to 15       345/359
(96 %)
0 diff
(100 %id)
FN119963 breast carcinoma .m 1029 to 1124 95 to 1     Submitted on the opposite strand 95/95
(100 %)
1 diff
(99.0 %id)
AI696674 Prostate .m 1036 to 1367 333 to 1       333/333
(100 %)
2 diff
(99.4 %id)
AA931393 Kidney .m 1037 to 1367 331 to 1       331/331
(100 %)
0 diff
(100 %id)
CA312991 Human Lung Epithelial cells, lung .m 1039 to 1367 347 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 329/356
(92 %)
7 diff
(98.1 %id)
FN136700 breast carcinoma .m 1060 to 1161 103 to 1     Submitted on the opposite strand 103/103
(100 %)
1 diff
(99.1 %id)
BF812343 colon_ins .m 1063 to 1252 200 to 10     Submitted on the opposite strand 191/200
(95 %)
0 diff
(100 %id)
BF812340 colon_ins .m 1064 to 1250 187 to 1     Submitted on the opposite strand 187/187
(100 %)
0 diff
(100 %id)
AI276300 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 1064 to 1369 313 to 8       306/313
(97 %)
0 diff
(100 %id)
BG163416 hypernephroma, cell line, Kidney .m 1065 to 1367 1 to 303   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 303/303
(100 %)
0 diff
(100 %id)
AI701952 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 1082 to 1367 296 to 11   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 286/286
(100 %)
0 diff
(100 %id)
AW517980 Kidney, renal cell tumor .m 1085 to 1367 294 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 283/283
(100 %)
1 diff
(99.7 %id)
AI672008 Kidney .m 1089 to 1361 281 to 9       273/281
(97 %)
0 diff
(100 %id)
AA523855 colon .m 1093 to 1367 275 to 1       275/275
(100 %)
0 diff
(100 %id)
BF221580 Prostate .m 1094 to 1371 288 to 11   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 278/278
(100 %)
1 diff
(99.7 %id)
F32726 pectoral muscle (after mastectomy) .m 1114 to 1358 1 to 245       245/245
(100 %)
0 diff
(100 %id)
BF476488 Prostate .m 1143 to 1324 1 to 182     Submitted on the opposite strand 182/182
(100 %)
0 diff
(100 %id)
AI561287 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 1150 to 1373 225 to 2       224/225
(99 %)
0 diff
(100 %id)
BM986936 mixed .m 1169 to 1373 221 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 205/213
(96 %)
0 diff
(100 %id)
AI659778 Prostate .m 1185 to 1372 188 to 1       188/188
(100 %)
0 diff
(100 %id)
AI620933 Prostate .m 1185 to 1372 188 to 1       188/188
(100 %)
0 diff
(100 %id)
AI991805 Prostate .m 1185 to 1372 188 to 1       188/188
(100 %)
1 diff
(99.5 %id)
FN048370 breast carcinoma .m 1205 to 1255 51 to 1     Submitted on the opposite strand 51/51
(100 %)
0 diff
(100 %id)
CN268363 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 1244 to 1560 1 to 317       317/317
(100 %)
0 diff
(100 %id)
EC488919 Prostate .m 1279 to 1372 95 to 3       93/95
(97 %)
0 diff
(100 %id)
FN074193 breast carcinoma .m 1307 to 1379 1 to 73       73/75
(97 %)
5 diff
(93.4 %id)
BY999280   .m 1308 to 1369 1 to 62     Submitted on the opposite strand 62/63
(98 %)
1 diff
(98.5 %id)
AI222450 Kidney .m 1982 to 2279 316 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 298/298
(100 %)
4 diff
(98.7 %id)
BG687561 lung, mucoepidermoid carcinoma .m 2111 to 2186 600 to 681       648/874
(74 %)
22 diff
(97.5 %id)
BG770463 melanotic melanoma, high MDR (cell line), skin .n 1 to 740 1 to 740 exact tiling clone,   740/742
(99 %)
7 diff
(99.1 %id)
BG763464 melanotic melanoma, high MDR (cell line), skin .n 1 to 800 1 to 805 L28C S29Q A30R E32K R33G ...     805/809
(99 %)
12 diff
(98.6 %id)
AF004427 breast carcinoma .n 82 to 1166 1 to 1085 exact tiling clone,   1085/1085
(100 %)
0 diff
(100 %id)
BG149962 carcinoid, lung .o 1 to 362 13 to 374 exact tiling clone, Submitted on the opposite strand 362/374
(96 %)
6 diff
(98.4 %id)
BE669832 carcinoid, lung .o 38 to 507 1 to 470 exact   Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
BM702144 eye, optic nerve .o 60 to 653 1 to 594 exact     594/594
(100 %)
0 diff
(100 %id)
BI091199 cervix .o 63 to 932 1 to 869 exact AAA   869/894
(97 %)
10 diff
(98.9 %id)
BI862321 breast, mammary adenocarcinoma, cell line .o 73 to 853 13 to 793 exact     781/793
(98 %)
17 diff
(97.9 %id)
TI_57191880   .o 73 to 853 68 to 848 exact     781/793
(98 %)
17 diff
(97.9 %id)
BM687632 eye, eye anterior segment .o 78 to 657 1 to 578 exact     578/578
(100 %)
7 diff
(98.8 %id)
TI_149301415   .o 96 to 965 938 to 77 N2D L3D M4E N5* tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 862/963
(89 %)
9 diff
(99.1 %id)
BE619858 large cell carcinoma, lung .o 141 to 909 773 to 7       770/848
(90 %)
22 diff
(97.5 %id)
DA391610 thalamus .p-u 1 to 584 2 to 585   tiling clone, capped   584/584
(100 %)
0 diff
(100 %id)
DA646558 mammary gland .p-u 188 to 1018 2 to 831   tiling clone, capped   830/830
(100 %)
7 diff
(99.2 %id)
BU182961 bone marrow, from acute myelogenous leukemia .p-u 775 to 1509 1 to 743   tiling clone,   743/789
(94 %)
12 diff
(98.5 %id)
AW993881 breast_normal .p-u 1406 to 1995 594 to 1 Q3P N8Y I24S V77R L78V ... tiling clone, Submitted on the opposite strand 594/620
(95 %)
12 diff
(98.1 %id)
BF326638 breast_normal .p-u 1406 to 1995 615 to 28 exact tiling clone,   588/615
(95 %)
0 diff
(100 %id)
CD672612 eye, Iris .p-u 1929 to 2558 13 to 642   tiling clone,   630/642
(98 %)
6 diff
(99.1 %id)
TI_149280206   .q-u 1 to 619 707 to 85 exact AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 621/1102
(56 %)
0 diff
(100 %id)
BM969872 lung, Primary Lung Epithelial Cells .q-u 1 to 619 639 to 17 exact AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 621/638
(97 %)
0 diff
(100 %id)
AK090516 adrenal gland .q-u 1 to 2485 2 to 2486 exact tiling clone, available from FLJ,   2486/2486
(100 %)
1 diff
(100.0 %id)
DA013550 adrenal gland .q-u 1 to 563 2 to 564 exact capped   563/563
(100 %)
0 diff
(100 %id)
AI695210 Kidney .q-u 228 to 619 392 to 1 exact     392/392
(100 %)
0 diff
(100 %id)
BM676715 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q-u 454 to 619 184 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 166/175
(94 %)
0 diff
(100 %id)
BM715015 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q-u 454 to 634 1 to 181       181/185
(97 %)
1 diff
(99.5 %id)
BU739346 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q-u 454 to 619 184 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 166/175
(94 %)
0 diff
(100 %id)
CA406024 adipose .q-u 506 to 632 1 to 127       127/127
(100 %)
0 diff
(100 %id)
DB019439 esophageal, tumor tissue .q-u 587 to 1139 2 to 554   capped   553/553
(100 %)
4 diff
(99.3 %id)
TI_153955484   .q-u 1600 to 2117 84 to 601       518/519
(99 %)
4 diff
(99.3 %id)
BF364289 nervous_normal .q-u 1604 to 1745 159 to 18       142/162
(87 %)
0 diff
(100 %id)
BM688850 eye, optic nerve .q-u 1807 to 2155 3 to 351   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 349/351
(99 %)
5 diff
(98.6 %id)
DB295338 adrenal gland .q-u 1970 to 2485 516 to 1       516/516
(100 %)
0 diff
(100 %id)
BU727320 eye, optic nerve .q-u 2125 to 2481 375 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
DA029922   .r 1 to 557 2 to 558   tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
BE184998 head_neck .r 1369 to 2010 667 to 27 H23M A24P S25V A26P Q27R ... tiling clone, Submitted on the opposite strand 641/667
(96 %)
3 diff
(99.6 %id)
DB295766   .r 1907 to 2445 539 to 1   tiling clone,   539/539
(100 %)
0 diff
(100 %id)
AW513729 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .s-u 1 to 484 484 to 1   tiling clone,   484/484
(100 %)
0 diff
(100 %id)
BX476346   .s-u 285 to 814 1 to 530   tiling clone,   530/530
(100 %)
3 diff
(99.5 %id)
AL120549 amygdala .s-u 800 to 1372 1 to 573 exact tiling clone,   573/573
(100 %)
0 diff
(100 %id)
DA041947 bladder .s-u 1040 to 1608 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA188344 amygdala .s-u 1207 to 1752 2 to 547   tiling clone, capped   546/546
(100 %)
0 diff
(100 %id)
AA621783   .t-u 1 to 396 399 to 4   tiling clone,   396/399
(99 %)
0 diff
(100 %id)
BX485057   .t-u 193 to 732 1 to 539   tiling clone,   539/539
(100 %)
2 diff
(99.7 %id)
CK004675 brain/CNS, Human Brain - Frontal Cortex .t-u 538 to 1164 1 to 627 G6R L20Q F34I L69M tiling clone,   627/628
(99 %)
26 diff
(95.9 %id)
BF130466 hypernephroma, Kidney .t-u 1085 to 1583 1 to 498   tiling clone,   498/501
(99 %)
4 diff
(99.3 %id)
CB105074 Ascites, stomach Gene TPD52L1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q-u, .r, .s-u, .t-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI